Signalling pathways involved in the synergistic effects of human growth differentiation factor 9 and bone morphogenetic protein 15

Reproduction, Fertility and Development

Volumn 28, Issue 4, 2016, Pages 491-498

  Reader, Karen L ^a   Mottershead, David G ^b   Martin, Georgia A ^b   Gilchrist, Robert B ^b   Heath, Derek A ^c   McNatty, Kenneth P ^c   Juengel, Jennifer L ^a  

^a INVERMAY AGRICULTURAL CENTRE   (New Zealand)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

follicle; granulosa cells; oocyte; ovary; proliferation.

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; GROWTH DIFFERENTIATION FACTOR 9; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; THYMIDINE; BMP15 PROTEIN, HUMAN; GDF9 PROTEIN, HUMAN; RECEPTOR REGULATED SMAD PROTEIN;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; DNA SYNTHESIS; FEMALE; GRANULOSA CELL; MOUSE; NONHUMAN; RAT; SECOND MESSENGER; THYMIDINE INCORPORATION ASSAY; 129 MOUSE; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; DRUG POTENTIATION; HUMAN; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 15; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; GRANULOSA CELLS; GROWTH DIFFERENTIATION FACTOR 9; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE, 129 STRAIN; NF-KAPPA B; RATS, SPRAGUE-DAWLEY; SECOND MESSENGER SYSTEMS; SMAD PROTEINS, RECEPTOR-REGULATED;

EID: 84959352070     PISSN: 10313613     EISSN: 14485990     Source Type: Journal    
DOI: 10.1071/RD14099     Document Type: Article

References (34)

1. Chang, H. M., Cheng, J. C., Klausen, C., and Leung, P. C. (2013). BMP15 suppresses progesterone production by down-regulating StAR via ALK3 in human granulosa cells. Mol. Endocrinol. 27(12), 2093-2104. doi:10.1210/ME.2013-1233
2. Di Pasquale, E., Beck-Peccoz, P., and Persani, L. (2004). Hypergonadotrophic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am. J. Hum. Genet. 75(1), 106-111. doi:10.1086/422103
3. Dixit, H., Rao, L. K., Padmalatha, V., Kanakavalli, M., Deenadayal, M., Gupta, N., Chakravarty, B., and Singh, L. (2005). Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 12(6), 749-754. doi:10.1097/01.GME.0000184424.96437.7A
4. Edwards, S. J., Reader, K. L., Lun, S., Western, A., Lawrence, S., McNatty, K. P., and Juengel, J. L. (2008). The cooperative effect of growth and differentiation factor-9 and bone morphogenetic protein (BMP)-15 on granulosa cell function is modulated primarily through BMP receptor II. Endocrinology 149(3), 1026-1030. doi:10.1210/EN.2007-1328
5. Gilchrist, R. B., Ritter, L. J., and Armstrong, D. T. (2001). Mouse oocyte mitogenic activity is developmentally coordinated throughout folliculogenesis and meiotic maturation. Dev. Biol. 240(1), 289-298. doi:10.1006/DBIO.2001.0451
6. Gilchrist, R. B., Ritter, L. J., Myllymaa, S., Kaivo-Oja, N., Dragovic, R. A., Hickey, T. E., Ritvos, O., and Mottershead, D. G. (2006). Molecular basis of oocyte-paracrine signalling that promotes granulosa cell proliferation. J. Cell Sci. 119(Pt 18), 3811-3821. doi:10.1242/JCS.03105
7. Huang, Q., Cheung, A. P., Zhang, Y., Huang, H.-F., Auersperg, N., and Leung, P. C. K. (2009). Effects of growth differentiation factor 9 on cell cycle regulators and ERK42/44 in human granulosa cell proliferation. Am. J. Physiol. Endocrinol. Metab. 296(6), E1344-E1353. doi:10.1152/AJPENDO.90929.2008
8. Juengel, J. L., and McNatty, K. P. (2005). The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development. Hum. Reprod. Update 11(2), 143-160.
9. Kaivo-Oja, N., Mottershead, D. G., Mazerbourg, S., Myllymaa, S., Duprat, S., Gilchrist, R. B., Groome, N. P., Hsueh, A. J., and Ritvos, O. (2005). Adenoviral gene transfer allows SMAD-responsive gene promoter analyses and delineation of Type I receptor usage of transforming growth factor-beta family ligands in cultured human granulosa luteal cells. J. Clin. Endocrinol. Metab. 90(1), 271-278. doi:10.1210/JC.2004-1288
10. Lin, A. (2003). Activation of the JNK signalling pathway: breaking the brake on apoptosis. Bioessays 25(1), 17-24. doi:10.1002/BIES.10204
11. Lin, J. Y., Pitman, J., Bibby, A. H., Hudson, N. L., McIntosh, C. J., Juengel, J. L., and McNatty, K. P. (2012). Effects of species differences on oocyte regulation of granulosa cell function. Reproduction 144, 557-567. doi:10.1530/REP-12-0267
12. Mazerbourg, S., Klein, C., Roh, J., Kaivo-Oja, N., Mottershead, D. G., Korchynskyi, O., Ritvos, O., and Hsueh, A. J. (2004). Growth differentiation factor-9 signalling is mediated by the Type I receptor, activin receptor-like kinase 5. Mol. Endocrinol. 18(3), 653-665. doi:10.1210/ME.2003-0393
13. McIntosh, C. J., Lun, S., Lawrence, S., Western, A. H., McNatty, K. P., and Juengel, J. L. (2008). The pro-region of mouse BMP15 regulates the cooperative interactions of BMP15 and GDF9. Biol. Reprod. 79(5), 889-896. doi:10.1095/BIOLREPROD.108.068163
14. McNatty, K. P., Juengel, J. L., Reader, K. L., Lun, S., Myllymaa, S., Lawrence, S. B., Western, A., Meerasahib, M. F., Mottershead, D. G., Groome, N. P., Ritvos, O., and Laitinen, M. P. (2005a). Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function. Reproduction 129(4), 473-480. doi:10.1530/REP.1.0511
15. McNatty, K. P., Juengel, J. L., Reader, K. L., Lun, S., Myllymaa, S., Lawrence, S. B., Western, A., Meerasahib, M. F., Mottershead, D. G., Groome, N. P., Ritvos, O., and Laitinen, M. P. (2005b). Bone morphogenetic protein 15 and growth differentiation factor 9 co-operate to regulate granulosa cell function in ruminants. Reproduction 129(4), 481-487. doi:10.1530/REP.1.00517
16. McNatty, K. P., Smith, P., Moore, L. G., Reader, K., Lun, S., Hanrahan, J. P., Groome, N. P., Laitinen, M., Ritvos, O., and Juengel, J. L. (2005c). Oocyte-expressed genes affecting ovulation rate. Mol. Cell. Endocrinol. 234(1-2), 57-66. doi:10.1016/J.MCE.2004.08.013
17. Montgomery, G. W., Zhao, Z. Z., Marsh, A. J., Mayne, R., Treloar, S. A., James, M., Martin, N. G., Boomsma, D. I., and Duffy, D. L. (2004). A deletion mutation in GDF9 in sisters with spontaneous DZ twins. Twin Res. 7(6), 548-555. doi:10.1375/1369052042663823
18. Moore, R. K., Otsuka, F., and Shimasaki, S. (2003). Molecular basis of bone morphogenetic protein-15 signalling in granulosa cells. J. Biol. Chem. 278(1), 304-310. doi:10.1074/JBC.M207362200
19. Moore, R. K., Erickson, G. F., and Shimasaki, S. (2004). Are BMP-15 and GDF-9 primary determinants of ovulation quota in mammals? Trends Endocrinol. Metab. 15(8), 356-361. doi:10.1016/J.TEM.2004.08.008
20. Mottershead, D. G., and Watson, A. J. (2009). Oocyte peptides as paracrine tools for ovarian stimulation and oocyte maturation. Mol. Hum. Reprod. 15(12), 789-794. doi:10.1093/MOLEHR/GAP085
21. Mottershead, D. G., Pulkki, M. M., Muggalla, P., Pasternack, A., Tolonen, M., Myllymaa, S., Korchynskyi, O., Nishi, Y., Yanase, T., Lun, S., Juengel, J. L., Laitinen, M., and Ritvos, O. (2008). Characterisation of recombinant human growth differentiation factor-9 signalling in ovarian granulosa cells. Mol. Cell. Endocrinol. 283(1-2), 58-67. doi:10.1016/J.MCE.2007.11.007
22. Mottershead, D. G., Ritter, L. J., and Gilchrist, R. B. (2012). Signalling pathways mediating specific synergistic interactions between GDF9 and BMP15. Mol. Hum. Reprod. 18(3), 121-128. doi:10.1093/MOLEHR/GAR056
23. Mottershead, D. G., Harrison, C. A., Mueller, T. D., Stanton, P. G., Gilchrist, R. B., and McNatty, K. P. (2013). Growth differentiation factor 9:bone morphogenetic protein 15 (GDF9:BMP15) synergism and protein heterodimerisation. Proc. Natl. Acad. Sci. USA 110(25), E2257. doi:10.1073/PNAS.1303459110
24. Neyman, J., and Scott, E. L. (1960). Correction for bias introduced by a transformation of variables. Ann. Math. Stat. 31, 643-655. doi:10.1214/AOMS/1177705791
25. Patterson, H. D., and Thompson, R. (1971). Recovery of inter-block information when block sizes are unequal. Biometrika 58, 545-554. doi:10.1093/BIOMET/58.3.545
26. Peng, J., Li, Q., Wigglesworth, K., Rangarajan, A., Kattamuri, C., Peterson, R. T., Eppig, J. J., Thompson, T. B., and Matzuk, M. M. (2013). Growth differentiation factor 9:bone morphogenetic protein 15 heterodimers are potent regulators of ovarian functions. Proc. Natl. Acad. Sci. USA 110(8), E776-E785. doi:10.1073/PNAS.1218020110
27. Pulkki, M. M., Myllymaa, S., Pasternack, A., Lun, S., Ludlow, H., Al-Qahtani, A., Korchynskyi, O., Groome, N., Juengel, J. L., Kalkkinen, N., Laitinen, M., Ritvos, O., and Mottershead, D. G. (2011). The bioactivity of human bone morphogenetic protein-15 is sensitive to C-terminal modification: characterisation of the purified untagged processed mature region. Mol. Cell. Endocrinol. 332(1-2), 106-115. doi:10.1016/J.MCE.2010.10.002
28. Pulkki, M. M., Mottershead, D. G., Pasternack, A. H., Muggalla, P., Ludlow, H., van Dinther, M., Myllymaa, S., Koli, K., ten Dijke, P., Laitinen, M., and Ritvos, O. (2012). A covalently dimerised recombinant human bone morphogenetic protein-15 variant identifies bone morphogenetic protein receptor Type 1B as a key cell surface receptor on ovarian granulosa cells. Endocrinology 153(3), 1509-1518. doi:10.1210/EN.2010-1390
29. Reader, K. L., Heath, D. A., Lun, S., McIntosh, C. J., Western, A. H., Littlejohn, R. P., McNatty, K. P., and Juengel, J. L. (2011). Signalling pathways involved in the cooperative effects of ovine and murine GDF9+BMP15-stimulated thymidine uptake by rat granulosa cells. Reproduction 142(1), 123-131. doi:10.1530/REP-10-0490
30. Shimasaki, S., Moore, R. K., Otsuka, F., and Erickson, G. F. (2004). The bone morphogenetic protein system in mammalian reproduction. Endocr. Rev. 25(1), 72-101. doi:10.1210/ER.2003-0007
31. Sugiura, K., Su, Y.-Q., Li, Q., Wigglesworth, K., Matzuk, M. M., and Eppig, J. J. (2010). Oestrogen promotes the development of mouse cumulus cells in coordination with oocyte-derived GDF9 and BMP15. Mol. Endocrinol. 24(12), 2303-2314. doi:10.1210/ME.2010-0260
32. Teixeira Filho, F. L., Baracat, E. C., Lee, T. H., Suh, C. S., Matsui, M., Chang, R. J., Shimasaki, S., and Erickson, G. F. (2002). Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 87(3), 1337-1344. doi:10.1210/JCEM.87.3.8316
33. Verbyla, A. P., Cullis, B. R., Kenward, M. G., and Welham, S. J. (1999). The analysis of designed experiments and longitudinal data by using smoothing splines. J. R. Stat. Soc. Ser. C Appl. Stat. 48(3), 269-311. doi:10.1111/1467-9876.00154
34. Vitt, U. A., Mazerbourg, S., Klein, C., and Hsueh, A. J. (2002). Bone morphogenetic protein receptor Type II is a receptor for growth differentiation factor-9. Biol. Reprod. 67(2), 473-480. doi:10.1095/BIOLREPROD67.2.473